Yüklüyor......
Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
BACKGROUND: We investigated the predictive markers for the therapeutic efficacy and the best combination of sodium-glucose co-transporter 2 (SGLT2) inhibitors (empagliflozin, dapagliflozin, and ipragliflozin) therapy in patients with type 2 diabetes mellitus (T2DM). METHODS: A total of 804 patients...
Kaydedildi:
| Yayımlandı: | Diabetes Metab J |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Korean Diabetes Association
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6470102/ https://ncbi.nlm.nih.gov/pubmed/30688052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2018.0057 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|